DOD Bone Marrow Failure Research Program Funding Opportunities

How to Apply: 

The FY22 BMFRP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website.  . 

 

Applications submitted to the FY22 BMFRP must address one or more of the following focus areas:

 

•             Understand the causes and progression of BMF diseases

•             Find effective BMF treatments and cures

 

Funding Opportunities-FY22 Bone Marrow Failure Research Program, Congressionally Directed Medical Research Programs (CDMRP) (army.mil)

 

Idea Development Award – Preproposal due June 29, 2022

Established Investigator: Independent investigators at or above the level of Associate Professor (or equivalent) or an Assistant Professor (or equivalent) with 10 years or more from their first faculty appointment (or equivalent) by the application submission deadline.

Early Career Investigators: Independent investigators at the level of Assistant Professor (or equivalent), and within 10 years from their first faculty appointment (or equivalent) by the application submission deadline.

•             Supports innovative ideas and high-impact approaches based on scientifically sound evidence in order to move toward the vision to understand and cure bone marrow failure (BMF) diseases.

•             Proposed research should have a high probability of revealing new avenues of investigation.

•             Research project should include a well–formulated, testable hypothesis and a well-developed and articulated research approach.

•             Must address at least one of the FY22 BMFRP IDA Focus Areas.

•             Strong BMF research team.

•             May include relevant preliminary data.

•             Clinical trials are not allowed.

•             Translational potential should be considered and described.

•             Pre-application submission is required; application submission is by invitation only.

•             The maximum allowable funding for the entire period of performance is $450,000 for direct costs.

•             Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

•             The maximum period of performance is 3 years.

 

Investigator-Initiated Research Award (IIRA) – Preproposal due June 29, 2022

Investigators at or above the level of Assistant Professor (or equivalent) by the application submission deadline.

Two funding levels of intent:

Funding Level 1: Supports studies that further develop ideas, expand upon key discoveries, and have the potential to make significant advances in BMF research, patient care, and/or quality of life. Correlative studies to existing clinical trials/studies are encouraged. Translational potential should be considered and described.

o             Funding Level 2: Investigational New Drug (IND)-enabling efforts The proposed studies should be empirical in nature, product driven, and focused on the accumulation of data to support an IND application to the U.S. Food and Drug Administration.  Applicants are required to identify lead BMF therapy candidate(s), and transition plans should be considered and adequately described.

•             Emphasis on Research Approach and Impact.

•             Strong BMF research team.

•             Preliminary data required.

•             Clinical trials are not allowed.

•             Must address at least one of the FY22 BMFRP IIRA Focus Areas.

•             Partnering PI Option: Allows two PIs, termed Initiating and Partnering PIs, to collaborate on a single application.

•             Pre-application submission is required; application submission is by invitation only

Funding Level 1:

•             The maximum allowable funding for the entire period of performance is $600,000 for direct costs.

•             Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

•             The maximum period of performance is 3 years.

Funding Level 2:

•             The maximum allowable funding for the entire period of performance is $800,000 for direct costs.

•             Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

•             The maximum period of performance is 2 years.

 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final funding opportunity announcements available for downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

 

For email notification when announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the BMFRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

 

Point of Contact:

CDMRP Help Desk

301-682-5507

help@eBrap.org

 

Please contact Jill Sherman, International Research Facilitator, for more information at intl.research@lakeheadu.ca .

External Deadline: 
Wednesday, June 29, 2022
Funding Source: 
External
Funding Level: 
Research